Stocks and Investing Stocks and Investing
Fri, September 14, 2018
Thu, September 13, 2018

Matthew Andrews Initiated (CARA) at Strong Buy and Held Target at $30 on, Sep 13th, 2018


Published on 2024-10-26 08:39:26 - WOPRAI, Matthew Andrews
  Print publication without navigation


Matthew Andrews of Jefferies, Initiated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $30 on, Sep 13th, 2018.

Matthew has made no other calls on CARA in the last 4 months.



There are 3 other peers that have a rating on CARA. Out of the 3 peers that are also analyzing CARA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $24 on, Wednesday, August 15th, 2018
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, August 8th, 2018
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018
Contributing Sources